Vistagen Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.56

+0.06 (+11.52%)

As of Feb 8, 2:24 PM ET ·

Analyst Consensus

Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 7 70%

Sell 3 30%

Price Target

Analyst Price Target +8,683.7% upside

Low Target $36.23

Average Target $49.47

High Target $53.77

Current Price $0.56

Current
$0.56

Target
$49.47

$36.23 $49.47 avg $53.77

Scenario Analysis

Bear Case

$36.23

6,332.9%

Low target

Base Case

$49.47

+8,683.7%

Avg target

Bull Case

$53.77

+9,447.2%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$43.60

-98.7% from high

52-Week Low

$20.48

+-97.3% from low

Target vs 52W High

$49.47

+13.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%